A Novel Toll-Like Receptor 9 Agonist Cooperates With Trastuzumab in Trastuzumab-Resistant Breast Tumors Through Multiple Mechanisms of Action
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-1599
Full Text
Open PDFAbstract
Available in full text
Date
November 10, 2009
Authors
Publisher
American Association for Cancer Research (AACR)